This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Los Alamos National Security, LLC, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009-2014.
Company Filing History:
1 out of 576 
1 out of 3,693 
Years Active: 2009-2014
Title: Anne E Boyer: Innovator in Rapid Detection Technologies
Introduction
Anne E Boyer is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of rapid detection technologies, particularly in the diagnosis of anthrax and botulinum neurotoxins. With a total of 2 patents, her work has the potential to save lives by enabling quicker diagnosis and treatment.
Latest Patents
One of her latest patents focuses on the detection of anthrax pathogenicity factors. This invention addresses a critical issue in current diagnosis methods, which often take several days to yield results. By reducing the diagnosis time to as little as four hours, this innovation allows for same-day identification of anthrax, significantly increasing the chances of effective treatment and patient recovery. The invention utilizes novel purification and detection techniques to reliably measure anthrax lethal factor in biological samples.
Another significant patent involves mass spectrometry-based methods for detecting clostridial neurotoxins. This method allows for the detection of neurotoxins in a sample by mixing it with a peptide substrate and measuring the proteolytic activity through mass spectroscopy. This innovative approach enhances the ability to identify harmful neurotoxins quickly and accurately.
Career Highlights
Anne E Boyer has worked with notable organizations such as Los Alamos National Security, LLC and the United States Department of Health and Human Services. Her experience in these institutions has contributed to her expertise in developing rapid detection methods for dangerous pathogens.
Collaborations
Throughout her career, Anne has collaborated with esteemed colleagues, including John R Barr and Conrad Padraig Quinn. These partnerships have furthered her research and development efforts in the field of pathogen detection.
Conclusion
Anne E Boyer is a trailblazer in the realm of rapid detection technologies, with her innovative patents poised to revolutionize the diagnosis of anthrax and neurotoxins. Her work exemplifies the critical intersection of science and public health, ultimately aiming to enhance patient outcomes.